
Board approved the Un-Audited Financial Results (Standalone and Consolidated) for the 2nd quarter/1st half year of FY 2024-25 ended on September 30, 2024 of the Company.
Filed with BSE ·

Board approved the Un-Audited Financial Results (Standalone and Consolidated) for the 2nd quarter/1st half year of FY 2024-25 ended on September 30, 2024 of the Company.
6ix hasn’t read this filing yet.
View original source (BSE India)Sunil Healthcare Ltd. on 6ix
Follow Sunil Healthcare into a list and get an email when it puts out news.
Follow Sunil Healthcare